Uniting pharma, DTx companies and healthcare institutions, the Clinically Validated DTx Summit is solely focused on the actionable uses of digital therapeutics to deliver radically improved patient outcomes.
Rapid developments in the field come with deep challenges, from navigating the regulatory landscape and demonstrating robust validation to successfully integrating these products into the day-to-day lives of physicians and complex healthcare workflows.
Built with leading industry, clinical and regulatory insight, the meeting covers four key pillars for successfully translating, integrating and commercializing digital therapeutics:
• Robust clinical trial development and execution
• Regulatory pathways and approvals
• Strategies to demonstrate value for reimbursement
• Integration into the clinic
Join the leaders from Highmark Health, Rx.Health, Digital Therapeutics Alliance, Omada Health, Dthera Sciences, Click Therapeutics and many more to use evidence-driven case studies to differentiate yourself from ‘wellness apps’.
December 4-5, 2019
+1 617 455 4188
Drug Developer or Digital Therapeutics Company* (Conference Only): USD 1899.00
Digital Health Service Provider (Conference Only): USD 2899.00
Speakers: Matthew Tucker, Director, Enterprise Strategy and Innovation, Highmark Health, Shrawan Patel, Vice President and Head, Clinical Transformation, Rx.Health, Megan Coder, Executive Director, Digital Therapeutics Alliance, Maria Latushkin, Senior Vice President, Engineering, Omada Health, Martin Culjat, Senior Vice President, Scientific and Regulatory Affairs, Dthera Sciences, Joel Sangerman, Chief Commercial Officer, Click Therapeutics